Literature DB >> 24552076

Expanding the frame of "voluntariness" in informed consent: structural coercion and the power of social and economic context.

Jill A Fisher1.   

Abstract

This paper introduces the term "structural coercion" to underscore the ways in which broader social, economic, and political contexts act upon individuals to compel them to enroll as subjects in clinical research. The paper challenges the adequacy of the concepts of "coercion" and "undue influence" in determining when research participation is voluntary. Acknowledging structural coercion shifts the frame of ethical deliberation away from specific individuals and specific studies to see important patterns in research participation by salient demographic characteristics. The effects of structural coercion manifest themselves in particular research settings, but unlike the conventional form of coercion, it is not rooted in the researcher-participant relationship or linked to particular study protocols. By extracting voluntariness from entrenched conceptions of the researcher-participant dyad, this paper proposes approaches to minimize the effects of structural coercion while creating new ethical imaginaries for review boards and researchers alike.

Entities:  

Mesh:

Year:  2013        PMID: 24552076     DOI: 10.1353/ken.2013.0018

Source DB:  PubMed          Journal:  Kennedy Inst Ethics J        ISSN: 1054-6863


  27 in total

1.  Captive to the Clinic: Phase I Clinical Trials as Temporal Total Institutions.

Authors:  Quintin Williams; Jill A Fisher
Journal:  Sociol Inq       Date:  2018-04-20

2.  Risk and Emotion Among Healthy Volunteers in Clinical Trials.

Authors:  Marci D Cottingham; Jill A Fisher
Journal:  Soc Psychol Q       Date:  2016-07-29

3.  Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical Trials.

Authors:  Jill A Fisher
Journal:  Sci Technol Human Values       Date:  2015-03-01

4.  'I'm still a hustler': entrepreneurial responses to precarity by participants in phase I clinical trials.

Authors:  Torin Monahan; Jill A Fisher
Journal:  Econ Soc       Date:  2016-01-06

5.  Research altruism as motivation for participation in community-centered environmental health research.

Authors:  Jennifer S Carrera; Phil Brown; Julia Green Brody; Rachel Morello-Frosch
Journal:  Soc Sci Med       Date:  2017-11-21       Impact factor: 4.634

6.  Ethical considerations in placebo-controlled randomised clinical trials.

Authors:  Kenneth R Kaufman
Journal:  BJPsych Open       Date:  2015-06-30

7.  Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings.

Authors:  George Mtove; Joshua Kimani; William Kisinza; Geofrey Makenga; Peter Mangesho; Stephan Duparc; Miriam Nakalembe; Kamija S Phiri; Russell Orrico; Ricardo Rojo; Pol Vandenbroucke
Journal:  Trials       Date:  2018-03-22       Impact factor: 2.279

8.  Participant Engagement in Translational Genomics Research: Respect for Persons-and Then Some.

Authors:  Janet E Childerhose; Candice R Finnila; Joon-Ho Yu; Barbara A Koenig; Jean McEwen; Stacey L Berg; Benjamin S Wilfond; Paul S Appelbaum; Kyle B Brothers
Journal:  Ethics Hum Res       Date:  2019-09

9.  Experiencing everyday ethics in context: frontline data collectors perspectives and practices of bioethics.

Authors:  Patricia Kingori
Journal:  Soc Sci Med       Date:  2013-10-25       Impact factor: 4.634

10.  The 'empty choice': A sociological examination of choosing medical research participation in resource-limited Sub-Saharan Africa.

Authors:  Patricia Kingori
Journal:  Curr Sociol       Date:  2015-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.